Video

Dr. Bianchi on Diagnostic Factors for AL Amyloidosis

Giada Bianchi, MD, discusses diagnostic factors for light chain amyloidosis.

Giada Bianchi, MD, a physician at Dana-Farber Cancer Institute, and an instructor in medicine at Harvard Medical School, discusses diagnostic factors for light chain (AL) amyloidosis.

Diagnostic delay remains as a notable challenge in AL amyloidosis, according to Bianchi. Patients who have advanced cardiac involvement often express disease symptoms for months and possibly years, Bianchi explains. Notably, this disease is a mimicker and can present with subtle symptoms at the outset, which can make the diagnostic process challenging, she says.

Depending on the organ that is involved, patients can present with a variety of symptoms. ​​​​​​​As such, it is important to be aware that any patient who has progressive symptoms of unclear nature, particularly those with smoldering myeloma, should be screened for AL amyloidosis, Bianchi concludes.

Related Videos
Mansi R. Shah, MD
Elizabeth Buchbinder, MD
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Nosha Farhadfar, MD, and Chandler Park, MD, FACP
C. Ola Landgren, MD, PhD
Robert M. Rifkin, MD
David Samuel Dicapua Siegel, MD
Marcella Ali Kaddoura, MD
Muhamed Baljevic, MD, FACP and Jorge Cortes, MD, discuss upcoming studies and emerging data being presented at the 2024 ASH Annual Meeting.
Shaji Kumar, MD